255 results on '"Moore, Ronald B."'
Search Results
52. Malignant spinal cord compression secondary to testicular seminoma at the time of initial presentation and at relapse while on surveillance
53. 308 DETECTION OF FUNCTIONAL CHANGES IN RENAL CELL CARCINOMA WITH POSITRON EMISSION TOMOGRAPHY
54. Adverse Renal Outcomes in Subjects Undergoing Nephrectomy for Renal Tumors: A Population-Based Analysis
55. Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model
56. The Prognostic Utility of Deceased Donor Implantation Biopsy in Determining Function and Graft Survival After Kidney Transplantation
57. ASSOCIATION BETWEEN COMORBIDITY AND SURVIVAL AFTER RADICAL CYSTECTOMY: RESULTS FROM THE ALBERTA UROLOGY INSTITUTE RADICAL CYSTECTOMY DATABASE
58. Dosimetric considerations of interstitial photodynamic therapy of the canine prostate mediated by intra-arterially administered hypocrellin derivative
59. Fractionated versus Standard Continuous Light Delivery in Interstitial Photodynamic Therapy of Dunning Prostate Carcinomas
60. Photodynamic Therapy of the Canine Prostate: Intra-arterial Drug Delivery
61. Monitoring photodynamic therapy with photoacoustic microscopy.
62. Using fluorescence to augment the efficacy of photodynamic therapy
63. Light dosimetry for multiple cylindrical diffusing sources for use in photodynamic therapy
64. Fractionated PDT light delivery system based on fiber optic switching technology
65. Selective reovirus killing of bladder cancer in a co-culture spheroid model
66. Leiomyosarcoma of the Bladder in a Retinoblastoma Patient
67. Fractionated PDT light delivery system based upon fibre optic switching technology
68. Dosimetric considerations of interstitial photodynamic therapy of the canine prostate mediated by intra-arterially administered hypocrellin derivative.
69. Using fluorescence to augment the efficacy of photodynamic therapy.
70. Predicting fluence measurements from a cylindrical diffusing tip using the P3-approximation
71. The Fluorescence Biodistribution And Kinetics Of Aminolevulinic Acid Induced Protoporphyrin IX In The Bladder Of A Rat Model With Orthotopic Urothelial Carcinoma
72. Using radiance predicted by the P3-approximation for treatment planning for PDT for prostatic carcinoma
73. Using radiance predicted by the P3 approximation in a spherical geometry to predict tissue optical properties
74. Using radiance predicted by the P3-approximation for treatment planning for PDT for prostatic carcinoma.
75. Radiance modelling using the P3 approximation
76. Biodistribution of Photofrin II® and 5-Aminolevulinic Acid-Induced Protoporphyrin IX in Normal Rat Bladder and Bladder Tumor Models: Implications for Photodynamic Therapy
77. Monte Carlo modelling of angular radiance in tissue phantoms and human prostate: PDT light dosimetry
78. Preclinical Assessment of Hypocrellin B and Hypocrellin B Derivatives as Sensitizers for Photodynamic Therapy of Cancer: Progress Update
79. In vivo light transmission spectra in EMT6/Ed murine tumors and dunning R3327 rat prostate tumors during photodynamic therapy
80. Preclinical assessment of the new 1440-nm-wavelength Nd:YAG laser for fragmenting ureteral calculi in an ex-vivo pig model
81. In-vitro studies investigating the stone-fragmenting parameters of the multi-YAG laser
82. Anisotropy of radiance in tissue phantoms and Dunning R3327 rat tumors: Radiance measurements with flat cleaved fiber probes
83. Photosensitization by anticancer agents 21: New perylene- and aminonaphthoquinones
84. Synthesis and biodistribution of 14C‐radiolabelled hypocrellin B
85. UPTAKE KINETICS AND INTRACELLULAR LOCALIZATION OF HYPOCRELLIN PHOTOSENSITIZERS FOR PHOTODYNAMIC THERAPY: A CONFOCAL MICROSCOPY STUDY
86. Intracellular uptake kinetics of hypocrellin photosensitizers for photodynamic therapy
87. Light distribution and optical coefficients in prostate tumor
88. Urothelial conversion of 5-aminolevulinic acid to protoporphyrin IX following oral or intravesical administration
89. Merkel Cell Carcinoma of the Scrotum
90. In-vitro studies investigating the stone-fragmenting parameters of the multi-YAG laser.
91. Preclinical assessment of the new 1440-nm-wavelength Nd:YAG laser for fragmenting ureteral calculi in an ex-vivo pig model.
92. FGD5 regulates endothelial cell PI3 kinase-β to promote neo-angiogenesis.
93. Dr. Malcolm S. McPhee.
94. Measurement of PDT-Induced Hypoxia in Dunning Prostate Tumors by Iodine-123-Iodoazomycin Arabinoside.
95. Intracellular uptake kinetics of hypocrellin photosensitizers for photodynamic therapy
96. Urothelial conversion of 5-aminolevulinic acid to protoporphyrin IX following oral or intravesical administration
97. Light distribution and optical coefficients in prostate tumor
98. Readers report.
99. Readers report.
100. Light dosimetry using the P3 approximation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.